At Kura Oncology, They are committed to realizing the promise of precision medicines for cancer. The genomics revolution is transforming how they treat cancer. They now understand that how a patient responds to treatment depends in part on the genetic makeup of the cancer and, importantly, we have the knowledge and tools to create targeted treatments and companion diagnostics to identify those patients most likely to benefit. This new era offers the potential for innovative treatments that are safer and more effective for patients with particular cancers. They are leveraging our insights into cancer genetics as well as our core strength of translating novel science into life-saving medicines to advance a pipeline of precision medicines. Their development programs target cancers with high unmet need, including lung, colorectal, thyroid and pancreatic cancers as well as blood cancers such as lymphoma and leukemias.
Kura Oncology's core mission is centered around the discovery and development of innovative therapeutics for the treatment of cancer. Their primary objective is to create targeted, personalized medicine that addresses the unique genetic drivers of cancer, ultimately improving patient outcomes and quality of life. By leveraging cutting-edge research and a deep understanding of cancer biology, Kura Oncology strives to revolutionize cancer care and transform the lives of those affected by this devastating disease.
- Patient focus: Kura Oncology is dedicated to improving the lives of cancer patients, with a focus on developing innovative therapies that meet unmet medical needs.
- Scientific rigor: Kura Oncology's approach is grounded in scientific excellence, with a commitment to rigorous research and development that drives the discovery of new treatments.
- Collaboration: Kura Oncology values teamwork and collaboration, fostering a culture of open communication and shared problem-solving to achieve common goals.
- Integrity: Kura Oncology operates with the highest ethical standards, prioritizing transparency, honesty, and accountability in all aspects of its business.
Co-Founder & Chief Medical Officer
Co-founder & Chief Scientific Officer
Pete De Spain